Xourafa, Georgia http://orcid.org/0009-0008-1540-0310
Korbmacher, Melis
Roden, Michael http://orcid.org/0000-0001-8200-6382
Article History
Accepted: 29 August 2023
First Online: 16 October 2023
Competing interests
: M.R. has received personal fees for consulting from Eli Lilly, Novo Nordisk, Boehringer Ingelheim and Sanofi US, and has been supported for investigator-initiated trials by Boehringer Ingelheim, Novartis Pharma and Nutricia/Danone. The other authors declare no competing interests.